Evidence map›Paper›PMID 33947437›Full record

ArticleBiotechnology for biofuels2021

Increasing lipid yield in Yarrowia lipolytica through phosphoketolase and phosphotransacetylase expression in a phosphofructokinase deletion strain.

Annapurna Kamineni, Andrew L Consiglio, Kyle MacEwen, Shuyan Chen, Gamuchirai Chifamba, A Joe Shaw, Vasiliki Tsakraklides

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. 10 years of CRISPR/CAS genomic engineering in Yarrowia lipolytica.Bioprocess and biosystems engineering · 2026
    Review
  3. Article
  4. Article
  5. Multidimensional Optimization ofBiodesign research · 2024
    Article
  6. Article
  7. Review
  8. Metabolic Engineering ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  9. Lipid Readjustment inBiomolecules · 2022
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Annapurna KamineniGinkgo Bioworks, 27 Drydock Ave, Boston, Massachusetts, United States. annapurna.kamineni@gmail.com.ORCID http://orcid.org/0000-0002-0346-7461
Andrew L ConsiglioGinkgo Bioworks, 27 Drydock Ave, Boston, Massachusetts, United States.
Kyle MacEwenGinkgo Bioworks, 27 Drydock Ave, Boston, Massachusetts, United States.
Shuyan ChenGinkgo Bioworks, 27 Drydock Ave, Boston, Massachusetts, United States.
Gamuchirai ChifambaGinkgo Bioworks, 27 Drydock Ave, Boston, Massachusetts, United States.
A Joe Shaw, Belmont, Massachusetts, United States.
Vasiliki TsakraklidesGinkgo Bioworks, 27 Drydock Ave, Boston, Massachusetts, United States.
Ginkgo Bioworks, Inc. (United States) · USBelmont Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLipids are important precursors in the biofuel and oleochemical industries. Yarrowia lipolytica is among the most extensively studied oleaginous microorganisms and has been a focus of metabolic engineering to improve lipid production. Yield improvement, through rewiring of the central carbon metabolism of Y. lipolytica from glucose to the lipid precursor acetyl-CoA, is a key strategy for achieving commercial success in this organism.

resultsBuilding on YB-392, a Y. lipolytica isolate known for stable non-hyphal growth and low citrate production with demonstrated potential for high lipid accumulation, we assembled a heterologous pathway that redirects carbon flux from glucose through the pentose phosphate pathway (PPP) to acetyl-CoA. We used phosphofructokinase (Pfk) deletion to block glycolysis and expressed two non-native enzymes, phosphoketolase (Xpk) and phosphotransacetylase (Pta), to convert PPP-produced xylulose-5-P to acetyl-CoA. Introduction of the pathway in a pfk deletion strain that is unable to grow and accumulate lipid from glucose in defined media ensured maximal redirection of carbon flux through Xpk/Pta. Expression of Xpk and Pta restored growth and lipid production from glucose. In 1-L bioreactors, the engineered strains recorded improved lipid yield and cell-specific productivity by up to 19 and 78%, respectively.

conclusionsYields and cell-specific productivities are important bioprocess parameters for large-scale lipid fermentations. Improving these parameters by engineering the Xpk/Pta pathway is an important step towards developing Y. lipolytica as an industrially preferred microbial biocatalyst for lipid production.

Indexed as

Cell-specific lipid productivityCentral carbon metabolismLipid yieldPhosphoketolasePhosphotransacetylaseYarrowia lipolytica

Identifiers

PMID33947437
PMCPMC8094482
OpenAlexW3159254634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.